Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 51

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 1
Chunk 51
---
Table of Contents                 

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Condensed Consolidated Statements of Income (Unaudited)For the three months ended March 31(In millions, except per share amounts)20252024Sales of products$3,117 $3,045 Sales of services1,660 1,605 Total revenues4,777 4,650 Cost of products1,963 1,967 Cost of services802 782 Gross profit2,012 1,902 Selling, general, and administrative1,040 1,038 Research and development344 324 Total operating expenses1,383 1,362 Operating income629 540 Interest and other financial charges – net110 122 Non-operating benefit (income) costs(74)(102)Other (income) expense – net(99)8 Income before income taxes692 512 Benefit (provision) for income taxes(104)(124)Net income588 388 Net (income) loss attributable to noncontrolling interests(24)(14)Net income attributable to GE HealthCare564 374 Earnings per share attributable to GE HealthCare:Basic$1.23 $0.82 Diluted1.23 0.81 Weighted-average number of shares outstanding:Basic457456Diluted459459

The accompanying notes are an integral part of these condensed consolidated financial statements. 

4

Table of Contents                 

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)For the three months ended March 31(In millions, net of tax)20252024Net income attributable to GE HealthCare$564 $374 Net income (loss) attributable to noncontrolling interests24 14 Net income588 388 Other comprehensive income (loss):Currency translation adjustments – net of taxes257 (76)Pension and Other Postretirement Plans – net of taxes(69)(35)Cash flow hedges – net of taxes(8)16 Other comprehensive income (loss)180 (95)Comprehensive income (loss)768 292 Less: Comprehensive income (loss) attributable to noncontrolling interests24 14 Comprehensive income attributable to GE HealthCare$744 $278 

The accompanying notes are an integral part of these condensed consolidated financial statements. 

5

Table of